| Dr Rebecca Brueggemann, | |
|
1268 E 32nd St, Silver City, NM 88061-7229 | |
| (575) 534-1919 | |
| (575) 534-0135 |
| Full Name | Dr Rebecca Brueggemann |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 7 Years |
| Location | 1268 E 32nd St, Silver City, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770899965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 7592 (Arizona) | Secondary |
| 225100000X | Physical Therapist | 5196 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Bone And Joint Institute, Pc | 5890717508 | 8 |
News Archive
The device industry has launched an aggressive campaign to avoid tighter Food and Drug Administration rules that would help generate the information needed to show whether newer devices are actually superior to the ones they replace.
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
Bacterin International Holdings, Inc. is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Scientists at the Boston Biomedical Research Institute identified Puma (p53 upregulated modulator of apoptosis) as a potential new target for the therapeutic intervention of heart disease.
› Verified 3 days ago
| Provider Name | Southwest Bone And Joint Institute, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841302379 PECOS PAC ID: 5890717508 Enrollment ID: O20051222000065 |
News Archive
The device industry has launched an aggressive campaign to avoid tighter Food and Drug Administration rules that would help generate the information needed to show whether newer devices are actually superior to the ones they replace.
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
Bacterin International Holdings, Inc. is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Scientists at the Boston Biomedical Research Institute identified Puma (p53 upregulated modulator of apoptosis) as a potential new target for the therapeutic intervention of heart disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebecca Brueggemann, 1268 E 32nd St, Silver City, NM 88061-7229 Ph: (575) 534-1919 | Dr Rebecca Brueggemann, 1268 E 32nd St, Silver City, NM 88061-7229 Ph: (575) 534-1919 |
News Archive
The device industry has launched an aggressive campaign to avoid tighter Food and Drug Administration rules that would help generate the information needed to show whether newer devices are actually superior to the ones they replace.
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
Bacterin International Holdings, Inc. is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.
Scientists at the Boston Biomedical Research Institute identified Puma (p53 upregulated modulator of apoptosis) as a potential new target for the therapeutic intervention of heart disease.
› Verified 3 days ago
Mr. Pedro Iniguez, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1310 N Pope St, Silver City, NM 88061 Phone: 505-388-0430 Fax: 505-388-0460 | |
Sally Jean Fitzgerald, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2317 Johnson Rd, Silver City, NM 88061 Phone: 505-534-0984 | |
Desert Springs Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 310 W 11th St, Silver City, NM 88061 Phone: 575-534-1187 Fax: 575-534-1439 | |
Mr. Scott Hill, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1268 E 32nd St, Silver City, NM 88061 Phone: 575-534-1919 Fax: 575-534-0135 | |
Dr. Min-hong Ding, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3514 N Fowler Ave, Silver City, NM 88061 Phone: 575-388-3127 | |
Mr. Zachary P Mead, M.S., P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1268 E 32nd St, Silver City, NM 88061 Phone: 505-534-1919 Fax: 505-534-0135 | |
Monica J. Rosson, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 505-956-2000 Fax: 505-956-2055 |